Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1B-peptide-CRM197 conjugate----1件: 11 💬
2B-STN DBS----1件: 6 💬
3B-VEC1件: Beremagene geperpavec1件: Beremagene geperpavec 💬 1件: COL7A 💬 2件: Cornified envelope formation, Protein digestion and absorption 💬1件: 36 💬
4B. lactis B94----1件: 193 💬
5B. theta----1件: 96 💬
6B001----1件: 13 💬
7B001 injection----1件: 13 💬
8B007----3件: 11, 35, 222 💬
9B02bx05----1件: 63 💬
10B03A A07----1件: 97 💬
11B03ac06----1件: 97 💬
12B03bb01----1件: 46 💬
13B2-asmedic----1件: 97 💬
14B6, B12, L-methylfolate----1件: 6 💬
15B6-solution----1件: 234 💬
16B: 2 dosis----1件: 97 💬
17Babaodan capsule----1件: 93 💬
18Bacille calmette-guerin vaccine----1件: 13 💬
19Bacille OF calmette-guerin----1件: 13 💬
20Bacillus coagulans1件: Bacillus coagulans---1件: 6 💬
21Bacillus licheniformis1件: Bacillus licheniformis---1件: 6 💬
22Bacillus subtilis1件: Bacillus subtilis---1件: 6 💬
23Background PAH therapy----1件: 86 💬
24Background treatment----1件: 46 💬
25Baclofen1件: Baclofen1件: Baclofen 💬 2件: GABBR,
GABBR 💬 		8件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬7件: 2, 10, 13, 18, 65, 149, 206 💬
26Baclofen (baclofen TAB. 10MG) treatment1件: Baclofen1件: Baclofen 💬 2件: GABBR,
GABBR 💬 		8件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬1件: 70 💬
27Baclofen 20 MG1件: Baclofen1件: Baclofen 💬 2件: GABBR,
GABBR 💬 		8件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬1件: 13 💬
28Baclofen ER capsules (GRS) 10 MG1件: Baclofen1件: Baclofen 💬 2件: GABBR,
GABBR 💬 		8件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬1件: 13 💬
29Baclofen ER capsules (GRS) 20 MG1件: Baclofen1件: Baclofen 💬 2件: GABBR,
GABBR 💬 		8件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬1件: 13 💬
30Baclofen ER capsules (GRS) 30MG1件: Baclofen1件: Baclofen 💬 2件: GABBR,
GABBR 💬 		8件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬1件: 13 💬
31Baclofen ER capsules (GRS) 40MG1件: Baclofen1件: Baclofen 💬 2件: GABBR,
GABBR 💬 		8件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬1件: 13 💬
32Baclofen ER capsules (GRS) 50 MG1件: Baclofen1件: Baclofen 💬 2件: GABBR,
GABBR 💬 		8件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬1件: 13 💬
33Baclofen IR1件: Baclofen1件: Baclofen 💬 2件: GABBR,
GABBR 💬 		8件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬1件: 13 💬
34Baclofen tablets USP 10 MG1件: Baclofen1件: Baclofen 💬 2件: GABBR,
GABBR 💬 		8件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬1件: 13 💬
35Baclofene----1件: 10 💬
36Bacteriophage----1件: 65 💬
37Bacteriophage preparation----1件: 96 💬
38Bacteriotherapy----2件: 96, 97 💬
39Bacteroides thetaiotaomicron1件: Bacteroides thetaiotaomicron---1件: 96 💬
40Bactrim2件: Sulfamethoxazole,
Trimethoprim		4件: Trimethoprim ,
Sulfamethoxazole ,
Trimethoprim sulfate ,
Trimethoprim hydrochloride 💬 		--1件: 299 💬
41BAF312----2件: 13, 50 💬
42BAF312 0,25 MG tablet----1件: 13 💬
43BAF312 0,5 MG tablet----1件: 50 💬
44BAF312 0.25 MG----1件: 50 💬
45BAF312 0.25 MG tablet----1件: 50 💬
46BAF312 0.25MG tablet----1件: 50 💬
47BAF312 0.5 MG----1件: 50 💬
48BAF312 0.50 MG----1件: 50 💬
49BAF312 1 MG----1件: 50 💬
50BAF312 1 MG tablet----2件: 13, 50 💬
51BAF312 1MG----1件: 50 💬
52BAF312 1MG tablet----1件: 50 💬
53BAF312 2 MG----1件: 50 💬
54BAF312 2 MG tablet----1件: 50 💬
55BAF312 2MG----1件: 50 💬
56BAF312 4 MG tablet----1件: 13 💬
57BAF312 4MG tablet----1件: 50 💬
58BAF312 5 MG tablet----1件: 50 💬
59BAF312 hemifumarate----2件: 13, 50 💬
60BAF312A----1件: 13 💬
61BAF312X----1件: 50 💬
62Bafiertam----1件: 13 💬
63Baitouweng tang----1件: 97 💬
64Baked milk----1件: 98 💬
65BAL----1件: 13 💬
66Balance & strengthening exercises1件: Isoxaflutole---1件: 6 💬
67Balance and coordination1件: Isoxaflutole---1件: 121 💬
68Balance and strengthening exercises1件: Isoxaflutole---1件: 6 💬
69Balance exercise1件: Isoxaflutole---2件: 6, 299 💬
70Balance exercise program using exoskeleton device1件: Isoxaflutole---1件: 13 💬
71Balance exercises1件: Isoxaflutole---1件: 13 💬
72Balance exercises with stroboscopic glasses1件: Isoxaflutole---1件: 13 💬
73Balance exercises with virtual reality glasses1件: Isoxaflutole---1件: 13 💬
74Balance exercises with visual-based metaphor training1件: Isoxaflutole---1件: 13 💬
75Balance platform therapy1件: Isoxaflutole---1件: 13 💬
76Balance targeted exercises1件: Isoxaflutole---1件: 13 💬
77Balance trainer balance exercises1件: Isoxaflutole---1件: 13 💬
78Balance training1件: Isoxaflutole---2件: 6, 13 💬
79Balance training BY means OF conventional rehabilitation1件: Isoxaflutole---1件: 18 💬
80Balance training over stabilometric platform1件: Isoxaflutole---1件: 18 💬
81Balanced diet----1件: 49 💬
82Ballon pulmonary angioplasty----1件: 88 💬
83Balloon pulmonary angioplasty----1件: 88 💬
84Balsalazide1件: Balsalazide2件: Balsalazide disodium ,
Balsalazide 💬 		--1件: 97 💬
85Balsalazide disodium1件: Balsalazide2件: Balsalazide disodium ,
Balsalazide 💬 		--1件: 97 💬
86Baminercept1件: Baminercept1件: Baminercept 💬 1件: LTB 💬 3件: Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Rheumatoid arthritis 💬3件: 13, 53, 97 💬
87Baminercept alfa1件: Baminercept1件: Baminercept 💬 1件: LTB 💬 3件: Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Rheumatoid arthritis 💬1件: 46 💬
88Bardoxolone methyl2件: Bardoxolone,
Bardoxolone methyl		2件: Bardoxolone ,
Bardoxolone methyl 💬 		--5件: 67, 84, 85, 86, 218 💬
89Bardoxolone methyl 10 MG2件: Bardoxolone,
Bardoxolone methyl		2件: Bardoxolone ,
Bardoxolone methyl 💬 		--1件: 67 💬
90Bardoxolone methyl 15 MG2件: Bardoxolone,
Bardoxolone methyl		2件: Bardoxolone ,
Bardoxolone methyl 💬 		--1件: 67 💬
91Bardoxolone methyl 20 MG2件: Bardoxolone,
Bardoxolone methyl		2件: Bardoxolone ,
Bardoxolone methyl 💬 		--1件: 67 💬
92Bardoxolone methyl 5 MG2件: Bardoxolone,
Bardoxolone methyl		2件: Bardoxolone ,
Bardoxolone methyl 💬 		--1件: 67 💬
93Bardoxolone methyl capsules2件: Bardoxolone,
Bardoxolone methyl		2件: Bardoxolone ,
Bardoxolone methyl 💬 		--4件: 66, 67, 86, 222 💬
94Bardoxolone methyl oral capsule2件: Bardoxolone,
Bardoxolone methyl		2件: Bardoxolone ,
Bardoxolone methyl 💬 		--1件: 67 💬
95Bardoxolone metile1件: Bardoxolone1件: Bardoxolone 💬 --1件: 67 💬
96Baricinitib----1件: 49 💬
97Baricitinib1件: Baricitinib1件: Baricitinib 💬 2件: JAK1,
JAK2 💬 		37件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬19件: 2, 13, 41, 46, 49, 50, 51, 53, 54, 93, 107, 135, 162, 265, 268, 269, 300, 325, 345 💬
98Baricitinib (LY3009104) 4 MG1件: Baricitinib1件: Baricitinib 💬 2件: JAK1,
JAK2 💬 		37件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬2件: 46, 84 💬
99Baricitinib 2 MG1件: Baricitinib1件: Baricitinib 💬 2件: JAK1,
JAK2 💬 		37件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬2件: 46, 53 💬
100Baricitinib 4 MG1件: Baricitinib1件: Baricitinib 💬 2件: JAK1,
JAK2 💬 		37件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬2件: 40, 46 💬
101Baricitinib 4 MG oral tablet1件: Baricitinib1件: Baricitinib 💬 2件: JAK1,
JAK2 💬 		37件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬1件: 46 💬
102Baricitinib blinded1件: Baricitinib1件: Baricitinib 💬 2件: JAK1,
JAK2 💬 		37件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬1件: 46 💬
103Baricitinib treatment1件: Baricitinib1件: Baricitinib 💬 2件: JAK1,
JAK2 💬 		37件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬1件: 46 💬
104Barium1件: Barium---2件: 2, 6 💬
105Barium esophagram1件: Barium---1件: 98 💬
106Barley1件: Barley---1件: 74 💬
107Barnascan----1件: 88 💬
108Barzolvolimab1件: Barzolvolimab1件: Barzolvolimab 💬 1件: KIT 💬 11件: Acute myeloid leukemia, Breast cancer, Central carbon metabolism in cancer, Hematopoietic cell lineage, MAPK signaling pathway, Melanogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway 💬1件: 98 💬
109Bascial prescription plus or minus herbs depend ON symptoms----1件: 97 💬
110BASE-edited hematopoietic stem and progenitor cells----1件: 65 💬
111Baseline blood tests----1件: 83 💬
112Baseline serum vitamin D level AT or above 50 nmol/L----1件: 46 💬
113Baseline serum vitamin D level below 50 nmol/L----1件: 46 💬
114Baseline treatment----1件: 13 💬
115Baseline WLL----1件: 229 💬
116Basic fibroblast growth factor1件: Basic Fibroblast Growth Factor---1件: 47 💬
117Basic treatment----1件: 51 💬
118Basic treatment: sulperazone + ursodeoxycholic acid + compound glycyrrhizin + methylprednisolone + vitamin AD , D , E , K + imipenem or meropenem----1件: 296 💬
119Basiliximab1件: Basiliximab1件: Basiliximab 💬 1件: IL2RA 💬 11件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬5件: 2, 50, 97, 222, 228 💬
120Basimglurant1件: Basimglurant1件: Basimglurant 💬 --1件: 158 💬
121Bassado----1件: 23 💬
122Bassado - 100 MG compresse 10 compresse----1件: 28 💬
123Bassado 10CPS 100MG----1件: 23 💬
124BAT1406----1件: 271 💬
125BAT1806----1件: 46 💬
126BAT1806 injection----1件: 46 💬
127BAT4406F----1件: 13 💬
128BAT4406F injection----1件: 13 💬
129Batoclimab1件: Batoclimab1件: Batoclimab 💬 --2件: 11, 14 💬
130Batoclimab 340 MG SC BI-weekly1件: Batoclimab1件: Batoclimab 💬 --1件: 11 💬
131Batoclimab 340 MG SC weekly1件: Batoclimab1件: Batoclimab 💬 --2件: 11, 14 💬
132Batoclimab 680 MG SC weekly1件: Batoclimab1件: Batoclimab 💬 --1件: 11 💬
133Batoclimab 680 milligrams (MG) subcutaneous (SC) weekly1件: Batoclimab1件: Batoclimab 💬 --1件: 14 💬
134Bavisant dihydrochloride monohydrate1件: Bavisant1件: Bavisant 💬 1件: HRH3 💬 2件: Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬1件: 6 💬
135Bavisant hydrochloride monohydrate1件: Bavisant1件: Bavisant 💬 1件: HRH3 💬 2件: Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬1件: 6 💬
136Bawei shenqi pill----1件: 271 💬
137BAX 111----1件: 288 💬
138BAX111----1件: 288 💬
139BAX930----1件: 64 💬
140BAX930 - recombinant human adamts131件: Apadamtase alfa2件: Apadamtase alfa ,
Apadamtase alfa and cinaxadamtase alfa 💬 		1件: ADAMTS13 💬 1件: Platelet activation 💬1件: 64 💬
141BAX930 or SHP655----1件: 64 💬
142BAX930 or SHP655 or TAK755----1件: 64 💬
143BAY 59-7939----1件: 210 💬
144BAY 63-2521----2件: 86, 88 💬
145BAY 63-2521 coated tablets 0.5 MG----2件: 86, 88 💬
146BAY 63-2521 coated tablets 1 MG----2件: 86, 88 💬
147BAY 63-2521 coated tablets 1.5 MG----2件: 86, 88 💬
148BAY 63-2521 coated tablets 2 MG----2件: 86, 88 💬
149BAY 63-2521 coated tablets 2.5 MG----2件: 86, 88 💬
150BAY 63-2521 IR coated tablet 1.0 MG----1件: 88 💬
151BAY 63-2521 IR coated tablet 1.5 MG----1件: 88 💬
152BAY 63-2521 IR coated tablet 2.0 MG----1件: 88 💬
153BAY 63-2521 IR coated tablet 2.5 MG----1件: 88 💬
154BAY 63-2521 IR tablet 0.5 MG----1件: 88 💬
155BAY 63-2521 IR tablet 1.0 MG----1件: 88 💬
156BAY 63-2521 IR tablet 1.5 MG----1件: 88 💬
157BAY 63-2521 IR tablet 2.0 MG----1件: 88 💬
158BAY 63-2521 IR tablet 2.5 MG----1件: 88 💬
159BAY 63-2521 IR tablets 0.5 MG----1件: 86 💬
160BAY 63-2521 IR tablets 1 MG----1件: 86 💬
161BAY 63-2521 IR tablets 1.0 MG----1件: 86 💬
162BAY 63-2521 IR tablets 1.5 MG----1件: 86 💬
163BAY 63-2521 IR tablets 2.0 MG----1件: 86 💬
164BAY 63-2521 IR tablets 2.5 MG----1件: 86 💬
165BAY 63-2521 tablet----1件: 86 💬
166BAY 63-2521 tablets 0.5 MG----2件: 86, 88 💬
167BAY 63-2521 tablets 1 MG----2件: 86, 88 💬
168BAY 63-2521 tablets 1.5 MG----2件: 86, 88 💬
169BAY 63-2521 tablets 2 MG----2件: 86, 88 💬
170BAY 63-2521 tablets 2.5 MG----2件: 86, 88 💬
171BAY 79-4998----1件: 13 💬
172BAY 80-6946----1件: 121 💬
173BAY 85-8501----1件: 299 💬
174BAY Q 3939----1件: 299 💬
175BAY Q 6256----1件: 86 💬
176BAY1237592----2件: 86, 88 💬
177BAY63-2521----4件: 51, 86, 88, 299 💬
178BAY85-8501----1件: 299 💬
179BAY86-5046----1件: 13 💬
180BAY86-5046_interferon-BETA-1B----1件: 13 💬
181BAYQ3939----1件: 299 💬
182Bazedoxifene acetate1件: Bazedoxifene1件: Bazedoxifene acetate 💬 2件: ESR1,
ESR2 💬 		10件: Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Estrogen signaling pathway, GnRH secretion, Hormone signaling, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬1件: 13 💬
183BB-301: dose escalation phase 1B cohort 11件: BB-301---1件: 113 💬
184BB-301: dose escalation phase 1B cohort 21件: BB-301---1件: 113 💬
185BB-301: dose escalation phase 1B cohort 31件: BB-301---1件: 113 💬
186BB-301: dose expansion phase 2A1件: BB-301---1件: 113 💬
187BBM-D101----1件: 113 💬
188BBM-F101 injection----1件: 19 💬
189BBP-418----1件: 113 💬
190BBP-6711件: BBP-671---2件: 245, 246 💬
191BBR 2778----2件: 11, 13 💬
192BBT-401-1S----1件: 97 💬
193BBT-401-1S, multiple doses----1件: 97 💬
194BBT-401-1S, single dose----1件: 97 💬
195BBT-8771件: BBT-877---1件: 85 💬
196BBT-877, multiple doses1件: BBT-877---1件: 85 💬
197BBT-877, single dose1件: BBT-877---1件: 85 💬
198BC7353----1件: 65 💬
199BCD-054 180 MCG----1件: 13 💬
200BCD-054 240 MCG----1件: 13 💬
201BCD-055----2件: 46, 271 💬
202BCD-063----1件: 13 💬
203BCD-085----2件: 93, 271 💬
204BCD-089----1件: 46 💬
205BCD-089, 162 MG, S/C, Q2W----1件: 46 💬
206BCD-089, 162 MG, S/C, QW----1件: 46 💬
207BCD-132----1件: 13 💬
208BCD-132, 125 MG----1件: 13 💬
209BCD-132, 500 MG----1件: 13 💬
210BCD-148----1件: 62 💬
211BCG tice vaccine----1件: 299 💬
212BCG20-0134----1件: 13 💬
213BCMA-CD19 CAR-T therapy----5件: 49, 51, 53, 56, 64 💬
214Bcma/CD19 CAR-T cells----2件: 49, 53 💬
215BCX100131件: BCX10013---1件: 62 💬
216BCX17725----1件: 160 💬
217BCX41611件: Avoralstat---1件: 65 💬
218BCX73531件: Berotralstat2件: Berotralstat ,
Berotralstat hydrochloride 💬 		1件: KLKB1 💬 1件: Complement and coagulation cascades 💬1件: 65 💬
219BCX7353 + digoxin1件: Berotralstat2件: Berotralstat ,
Berotralstat hydrochloride 💬 		1件: KLKB1 💬 1件: Complement and coagulation cascades 💬1件: 65 💬
220BCX7353 and probes1件: Berotralstat2件: Berotralstat ,
Berotralstat hydrochloride 💬 		1件: KLKB1 💬 1件: Complement and coagulation cascades 💬1件: 65 💬
221BCX7353 capsules1件: Berotralstat2件: Berotralstat ,
Berotralstat hydrochloride 💬 		1件: KLKB1 💬 1件: Complement and coagulation cascades 💬1件: 65 💬
222BCX9930----3件: 62, 66, 222 💬
223BCX9930 hydrochloride----3件: 62, 66, 222 💬
224BCX9930 monotherapy----1件: 62 💬
225Bdmard----1件: 46 💬
226Bdmard treatment----1件: 271 💬
227Bdmards----1件: 46 💬
228Beam1件: Tricyclazole---1件: 51 💬
229Beam regimen----1件: 13 💬
230Beam test TO predict falls1件: Tricyclazole---1件: 6 💬
231BEAM-302----1件: 231 💬
232Beck depression inventory----1件: 113 💬
233Beclometasone----1件: 97 💬
234Beclometasone dipropionate1件: Beclomethasone dipropionate3件: Beclomethasone dipropionate ,
Beclometasone ,
Beclomethasone dipropionate monohydrate 💬 		1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬2件: 85, 97 💬
235Beclomethasone dipropionate1件: Beclomethasone dipropionate3件: Beclomethasone dipropionate ,
Beclometasone ,
Beclomethasone dipropionate monohydrate 💬 		1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 98 💬
236Beclomethasone dipropionate IN addition TO MC-evoo1件: Beclomethasone dipropionate3件: Beclomethasone dipropionate ,
Beclometasone ,
Beclomethasone dipropionate monohydrate 💬 		1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 97 💬
237Beclomethasone dipropionate IN addition TO refined OIL1件: Beclomethasone dipropionate3件: Beclomethasone dipropionate ,
Beclometasone ,
Beclomethasone dipropionate monohydrate 💬 		1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 97 💬
238Beclomethasone diproprionate----1件: 97 💬
239BEE venom----1件: 6 💬
240BEE venom pharmacopuncture----1件: 70 💬
241BEET-IT juice1件: Beet---1件: 340 💬
242Beetainterferoni -1A----1件: 13 💬
243Beetroot juice----1件: 86 💬
244Beetroot juice extract----1件: 113 💬
245Befiradol1件: Befiradol---1件: 6 💬
246Befizal L.P. 400 MG, comprimé enrobé à LIBération prolongéE----1件: 94 💬
247Begelomab1件: Begelomab---1件: 50 💬
248Behavioral counseling----1件: 97 💬
249Behavioral health consultation/therapy----1件: 226 💬
250Belantamab mafodotin1件: Belantamab mafodotin1件: Belantamab mafodotin 💬 10件: TNFRSF17,
TUBB,
TUBB,
TUBB,
TUBB,
TUBB,
TUBB,
TUBB,
TUBB,
TUBB 💬 		13件: Alzheimer disease, Amyotrophic lateral sclerosis, Cytokine-cytokine receptor interaction, Gap junction, Huntington disease, Intestinal immune network for IgA production, Motor proteins, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Prion disease, Salmonella infection 💬1件: 28 💬
251Belantamab mafodotin every 4 weeks, 6 weeks,8 weeks, or 12 weeks AS determined BY part 1 recommended dosages1件: Belantamab mafodotin1件: Belantamab mafodotin 💬 10件: TNFRSF17,
TUBB,
TUBB,
TUBB,
TUBB,
TUBB,
TUBB,
TUBB,
TUBB,
TUBB 💬 		13件: Alzheimer disease, Amyotrophic lateral sclerosis, Cytokine-cytokine receptor interaction, Gap junction, Huntington disease, Intestinal immune network for IgA production, Motor proteins, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Prion disease, Salmonella infection 💬1件: 28 💬
252Belatacept1件: Belatacept1件: Belatacept 💬 2件: CD80,
CD86 💬 		13件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬1件: 46 💬
253Belcesiran1件: Belcesiran---1件: 231 💬
254Belimumab1件: Belimumab1件: Belimumab 💬 1件: TNFSF13B 💬 4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬13件: 11, 13, 43, 44, 46, 49, 51, 53, 63, 66, 95, 222, 296 💬
255Belimumab 1 MG/KG1件: Belimumab1件: Belimumab 💬 1件: TNFSF13B 💬 4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬2件: 46, 49 💬
256Belimumab 10 MG1件: Belimumab1件: Belimumab 💬 1件: TNFSF13B 💬 4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬1件: 222 💬
257Belimumab 10 MG/KG1件: Belimumab1件: Belimumab 💬 1件: TNFSF13B 💬 4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬3件: 43, 46, 49 💬
258Belimumab 10 MG/KG plus standard therapy1件: Belimumab1件: Belimumab 💬 1件: TNFSF13B 💬 4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬1件: 49 💬
259Belimumab 100 MG SC1件: Belimumab1件: Belimumab 💬 1件: TNFSF13B 💬 4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬1件: 49 💬
260Belimumab 10MG/KG1件: Belimumab1件: Belimumab 💬 1件: TNFSF13B 💬 4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬1件: 49 💬
261Belimumab 200 MG SC1件: Belimumab1件: Belimumab 💬 1件: TNFSF13B 💬 4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬1件: 49 💬
262Belimumab 200 MG/ML1件: Belimumab1件: Belimumab 💬 1件: TNFSF13B 💬 4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬1件: 49 💬
263Belimumab 4 MG/KG1件: Belimumab1件: Belimumab 💬 1件: TNFSF13B 💬 4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬2件: 46, 49 💬
264Belimumab autoinjector1件: Belimumab1件: Belimumab 💬 1件: TNFSF13B 💬 4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬1件: 49 💬
265Belimumab FOR IV1件: Belimumab1件: Belimumab 💬 1件: TNFSF13B 💬 4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬1件: 49 💬
266Belimumab FOR SC1件: Belimumab1件: Belimumab 💬 1件: TNFSF13B 💬 4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬1件: 49 💬
267Belimumab IN SLE patients / rituximab IN RA patients1件: Belimumab1件: Belimumab 💬 1件: TNFSF13B 💬 4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬2件: 46, 49 💬
268Belimumab injection1件: Belimumab1件: Belimumab 💬 1件: TNFSF13B 💬 4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬1件: 49 💬
269Belimumab or benlysta1件: Belimumab1件: Belimumab 💬 1件: TNFSF13B 💬 4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬1件: 49 💬
270Belimumab plus early vaccination1件: Belimumab1件: Belimumab 💬 1件: TNFSF13B 💬 4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬1件: 49 💬
271Belimumab plus late vaccination1件: Belimumab1件: Belimumab 💬 1件: TNFSF13B 💬 4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬1件: 49 💬
272Belimumab+SOC1件: Belimumab1件: Belimumab 💬 1件: TNFSF13B 💬 4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬1件: 48 💬
273Belumosudil1件: Belumosudil2件: Belumosudil ,
Belumosudil mesylate 💬 		1件: ROCK2 💬 22件: Adherens junction, Axon guidance, Chemokine signaling pathway, Focal adhesion, Human cytomegalovirus infection, Leukocyte transendothelial migration, Lipid and atherosclerosis, Oxytocin signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Platelet activation, Proteoglycans in cancer, Regulation of actin cytoskeleton, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Tight junction, Vascular smooth muscle contraction, Wnt signaling pathway, Yersinia infection, cAMP signaling pathway, cGMP-PKG signaling pathway 💬3件: 51, 85, 228 💬
274Bemdaneprocel----1件: 6 💬
275BEN-2001----1件: 6 💬
276Benazepril1件: Benazepril2件: Benazepril hydrochloride ,
Benazepril 💬 		1件: ACE 💬 6件: Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬2件: 57, 218 💬
277Benazepril hydrochloride 10 milligram (MG) TAB1件: Benazepril2件: Benazepril hydrochloride ,
Benazepril 💬 		1件: ACE 💬 6件: Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬1件: 218 💬
278Benazepril hydrochloride tablets1件: Benazepril2件: Benazepril hydrochloride ,
Benazepril 💬 		1件: ACE 💬 6件: Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬1件: 224 💬
279Benazepril pill1件: Benazepril2件: Benazepril hydrochloride ,
Benazepril 💬 		1件: ACE 💬 6件: Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬1件: 49 💬
280Benazepril, valsartan and fluvastatin1件: Benazepril2件: Benazepril hydrochloride ,
Benazepril 💬 		1件: ACE 💬 6件: Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬1件: 218 💬
281Bendamustine1件: Bendamustine3件: Bendamustine hydrochloride ,
Bendamustine ,
Bendamustine hydrochloride hydrate 💬 		--3件: 28, 49, 51 💬
282Bendamustine hydrochloride1件: Bendamustine3件: Bendamustine hydrochloride ,
Bendamustine ,
Bendamustine hydrochloride hydrate 💬 		--1件: 61 💬
283Bendamustine, rituximab1件: Bendamustine3件: Bendamustine hydrochloride ,
Bendamustine ,
Bendamustine hydrochloride hydrate 💬 		--1件: 61 💬
284Bendroflumethiazide1件: Bendroflumethiazide1件: Bendroflumethiazide 💬 1件: SLC12A3 💬 1件: Parathyroid hormone synthesis, secretion and action 💬1件: 67 💬
285Benepali1件: Etanercept1件: Etanercept 💬 2件: LTA,
TNF 💬 		66件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬2件: 46, 271 💬
286Benerva----1件: 8 💬
287Benlysta1件: Belimumab1件: Belimumab 💬 1件: TNFSF13B 💬 4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬3件: 49, 66, 222 💬
288Benlysta 400 MG powder FOR concentrate FOR solution FOR infusion1件: Belimumab1件: Belimumab 💬 1件: TNFSF13B 💬 4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬2件: 43, 49 💬
289Benlysta 400 MG powder FOR concentrate FOR solution FOR infusions1件: Belimumab1件: Belimumab 💬 1件: TNFSF13B 💬 4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬1件: 49 💬
290Benlysta 400MG polvere PER concentrato PER soluzione PER infusione1件: Belimumab1件: Belimumab 💬 1件: TNFSF13B 💬 4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬1件: 43 💬
291Benralizumab1件: Benralizumab1件: Benralizumab 💬 1件: IL5RA 💬 4件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬5件: 44, 45, 98, 162, 299 💬
292Benserazide1件: Benserazide2件: Benserazide hydrochloride ,
Benserazide 💬 		1件: DDC 💬 8件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬1件: 6 💬
293Benserazide hydrochloride1件: Benserazide2件: Benserazide hydrochloride ,
Benserazide 💬 		1件: DDC 💬 8件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬1件: 6 💬
294Benzathine penicillin----1件: 271 💬
295Benzbromaron AL----1件: 86 💬
296Benzbromarone1件: Benzbromarone1件: Benzbromarone 💬 --1件: 86 💬
297Benzilpenicillina benzatinica----1件: 62 💬
298Benzimidazole,5-methoxy-2-[[(4-methoxy- 3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-1 H-benzimidazole1件: Benzimidazole---1件: 46 💬
299Benzimidazole,5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-1 H-benzimidazole1件: Benzimidazole---1件: 46 💬
300Benzodiazepine1件: 1,2-Benzodiazepine---1件: 6 💬
301Bepranemab1件: Bepranemab1件: Bepranemab 💬 1件: MAPT 💬 4件: Alzheimer disease, MAPK signaling pathway, Parkinson disease, Pathways of neurodegeneration - multiple diseases 💬1件: 5 💬
302Berachin----1件: 6 💬
303Beraprost1件: Beraprost2件: Beraprost sodium ,
Beraprost 💬 		1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
304Beraprost sodium1件: Beraprost2件: Beraprost sodium ,
Beraprost 💬 		1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
305Beraprost sodium 314D modified release tablets1件: Beraprost2件: Beraprost sodium ,
Beraprost 💬 		1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
306Beraprost sodium modified release1件: Beraprost2件: Beraprost sodium ,
Beraprost 💬 		1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
307Berberine1件: Berberine1件: Coptis rhizome 💬 --3件: 46, 97, 265 💬
308Berberine chloride1件: Berberine1件: Coptis rhizome 💬 --1件: 97 💬
309Berg balance scale----4件: 6, 13, 113, 149 💬
310Berinert----1件: 65 💬
311Berinert P----1件: 65 💬
312Berinert*IV FL 500U+FL 10ML----1件: 65 💬
313Berinert, lyophilizate FOR IV application containing 500 IU C1-INH TO BE reconstituted with 10 ML water FOR injection1件: Human C1-esterase inhibitor---1件: 65 💬
314Berinert® P----1件: 65 💬
315Berinert®, 20 ??/ KG----1件: 65 💬
316Bermekimab1件: Bermekimab1件: Bermekimab 💬 1件: IL1A 💬 21件: AGE-RAGE signaling pathway in diabetic complications, Alzheimer disease, Cellular senescence, Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Inflammatory bowel disease, Influenza A, Leishmaniasis, MAPK signaling pathway, Measles, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Tuberculosis, Type I diabetes mellitus 💬1件: 51 💬
317Berotralstat1件: Berotralstat2件: Berotralstat ,
Berotralstat hydrochloride 💬 		1件: KLKB1 💬 1件: Complement and coagulation cascades 💬1件: 65 💬
318Bertilimumab1件: Bertilimumab---2件: 97, 162 💬
319Best medical therapy----1件: 97 💬
320Best medical treatment----1件: 6 💬
321Best medical treatment (BMT): adjustment OF THE dopaminergic medication and NON-dopaminergic therapy customized FOR each patient according TO THE latest published consensus group recommendations----1件: 6 💬
322Best medical treatment FOR management OF impulse control IN parkinson´S disease according TO widely accepted expert consensus paper----1件: 6 💬
323Best Médical treatment----1件: 6 💬
324Best practice----1件: 60 💬
325Beta carotene from dunaliella algae1件: Beta carotene1件: beta Carotene 💬 --1件: 96 💬
326BETA-1,3/1,6-D-glucan----1件: 97 💬
327BETA-1B interferoni----1件: 13 💬
328BETA-alanine1件: beta-Alanine1件: beta-Alanine 💬 --1件: 13 💬
329BETA-alanine supplementation1件: beta-Alanine1件: beta-Alanine 💬 --1件: 13 💬
330BETA-carotene1件: Beta carotene1件: beta Carotene 💬 --1件: 13 💬
331BETA-interferon----1件: 13 💬
332BETA-lactam antibiotic----1件: 299 💬
333Betacarotene1件: Beta carotene1件: beta Carotene 💬 --1件: 13 💬
334Betaconnect----1件: 13 💬
335Betaconnect AUTO-injector----1件: 13 💬
336Betaconnect autoinjector----1件: 13 💬
337Betaconnect device----1件: 13 💬
338Betaferon1件: Interferon beta-1b1件: Interferon beta-1b 💬 2件: IFNAR1,
IFNAR2 💬 		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
339Betaferon - 15 flaconcini 0.25 MG + 15 flaconcini 2 ML1件: Interferon beta-1b1件: Interferon beta-1b 💬 2件: IFNAR1,
IFNAR2 💬 		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
340Betaferon 250 MCG1件: Interferon beta-1b1件: Interferon beta-1b 💬 2件: IFNAR1,
IFNAR2 💬 		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
341Betaferon 250 microgram/ML1件: Interferon beta-1b1件: Interferon beta-1b 💬 2件: IFNAR1,
IFNAR2 💬 		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
342Betaferon 250 microgram/ML, powder and solvent FOR solution FOR injection1件: Interferon beta-1b1件: Interferon beta-1b 💬 2件: IFNAR1,
IFNAR2 💬 		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
343Betaferon 250 microgramos----1件: 13 💬
344Betaferon 250MCG----1件: 13 💬
345Betaferon 250µG1件: Interferon beta-1b1件: Interferon beta-1b 💬 2件: IFNAR1,
IFNAR2 💬 		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
346Betaferon 500 MCG1件: Interferon beta-1b1件: Interferon beta-1b 💬 2件: IFNAR1,
IFNAR2 💬 		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
347Betaferon 500 µG----1件: 13 💬
348Betaferon 500MCG----1件: 13 💬
349Betaferon 500µG1件: Interferon beta-1b1件: Interferon beta-1b 💬 2件: IFNAR1,
IFNAR2 💬 		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
350Betaferon SC 15F 0,25MG 15SIR1件: Interferon beta-1b1件: Interferon beta-1b 💬 2件: IFNAR1,
IFNAR2 💬 		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
351Betaferon, BAY86-50461件: Interferon beta-1b1件: Interferon beta-1b 💬 2件: IFNAR1,
IFNAR2 💬 		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
352Betaferon/betaseron1件: Interferon beta-1b1件: Interferon beta-1b 💬 2件: IFNAR1,
IFNAR2 💬 		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
353Betaine1件: Betaine3件: Betaine hydrochloride ,
Betaine ,
Betaine citrate 💬 		--4件: 117, 201, 234, 337 💬
354Betaloc ZOK 100, 95 MG----1件: 113 💬
355Betaloc ZOK 25, 23,75 MG----1件: 113 💬
356Betametasone DOC----1件: 90 💬
357Betamethasone1件: Betamethasone6件: Betamethasone ,
Betamethasone sodium phosphate ,
Betamethasone valerate ,
Betamethasone acetate ,
Betamethasone dipropionate ,
Betamethasone benzoate 💬 		1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬5件: 28, 83, 90, 96, 235 💬
358Betamethasone acibutate1件: Betamethasone6件: Betamethasone ,
Betamethasone sodium phosphate ,
Betamethasone valerate ,
Betamethasone acetate ,
Betamethasone dipropionate ,
Betamethasone benzoate 💬 		1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 46 💬
359Betamethasone mouthwash1件: Betamethasone6件: Betamethasone ,
Betamethasone sodium phosphate ,
Betamethasone valerate ,
Betamethasone acetate ,
Betamethasone dipropionate ,
Betamethasone benzoate 💬 		1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 56 💬
360Betamethasone oral solution period 1 and period 21件: Betamethasone6件: Betamethasone ,
Betamethasone sodium phosphate ,
Betamethasone valerate ,
Betamethasone acetate ,
Betamethasone dipropionate ,
Betamethasone benzoate 💬 		1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 65 💬
361Betamethasone sodium phosphate/betamethasone acetate (celestone® soluspan®), 30 MG IM once A DAY FOR four days1件: Betamethasone6件: Betamethasone ,
Betamethasone sodium phosphate ,
Betamethasone valerate ,
Betamethasone acetate ,
Betamethasone dipropionate ,
Betamethasone benzoate 💬 		1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 2 💬
362Betamethasone solution AS intramuscular injection period 1 and period 21件: Betamethasone6件: Betamethasone ,
Betamethasone sodium phosphate ,
Betamethasone valerate ,
Betamethasone acetate ,
Betamethasone dipropionate ,
Betamethasone benzoate 💬 		1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 65 💬
363Betaquik MCT supplement----1件: 6 💬
364Betaseron1件: Interferon beta-1b1件: Interferon beta-1b 💬 2件: IFNAR1,
IFNAR2 💬 		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
365Betaseron (interferon BETA-1B, BAY86-5046), bayer healthcare AG2件: Human interferon beta,
Interferon beta-1b		2件: Interferon beta-1b ,
Interferon beta 💬 		2件: IFNAR1,
IFNAR2 💬 		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
366Bethanechol1件: Bethanechol1件: Bethanechol chloride 💬 5件: CHRM1,
CHRM2,
CHRM3,
CHRM4,
CHRM5 💬 		14件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬1件: 98 💬
367Bethkis----1件: 299 💬
368Bevacizumab1件: Bevacizumab1件: Bevacizumab 💬 1件: VEGFA 💬 23件: AGE-RAGE signaling pathway in diabetic complications, Bladder cancer, Calcium signaling pathway, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Fluid shear stress and atherosclerosis, Focal adhesion, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, Kaposi sarcoma-associated herpesvirus infection, MAPK signaling pathway, MicroRNAs in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Relaxin signaling pathway, Renal cell carcinoma, Rheumatoid arthritis, VEGF signaling pathway 💬8件: 13, 34, 85, 87, 89, 227, 280, 331 💬
369Bevacizumab zirconium ZR-892件: Bevacizumab,
Bevacizumab zirconium Zr-89		1件: Bevacizumab 💬 1件: VEGFA 💬 23件: AGE-RAGE signaling pathway in diabetic complications, Bladder cancer, Calcium signaling pathway, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Fluid shear stress and atherosclerosis, Focal adhesion, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, Kaposi sarcoma-associated herpesvirus infection, MAPK signaling pathway, MicroRNAs in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Relaxin signaling pathway, Renal cell carcinoma, Rheumatoid arthritis, VEGF signaling pathway 💬1件: 34 💬
370Bevacuzimab spray----1件: 227 💬
371Bevantolol hydrochloride1件: Bevantolol1件: Bevantolol hydrochloride 💬 8件: ADRA1A,
ADRA1B,
ADRA1D,
ADRB1,
CACNA1C,
CACNA1D,
CACNA1F,
CACNA1S 💬 		44件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Gap junction, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hormone signaling, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Regulation of lipolysis in adipocytes, Renin secretion, Retrograde endocannabinoid signaling, Salivary secretion, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 8 💬
372Bevantololo cloridrato----1件: 8 💬
373Bexarotene1件: Bexarotene1件: Bexarotene 💬 3件: RXRA,
RXRB,
RXRG 💬 		18件: Adipocytokine signaling pathway, Bile secretion, Chemical carcinogenesis - receptor activation, Efferocytosis, Gastric cancer, Hepatitis C, Lipid and atherosclerosis, Non-alcoholic fatty liver disease, Non-small cell lung cancer, PI3K-Akt signaling pathway, PPAR signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Thyroid cancer, Thyroid hormone signaling pathway, Transcriptional misregulation in cancer 💬2件: 13, 75 💬
374Bexotegrast1件: Bexotegrast1件: Bexotegrast 💬 3件: ITGA5,
ITGB1,
ITGB6 💬 		31件: Arrhythmogenic right ventricular cardiomyopathy, Axon guidance, Bacterial invasion of epithelial cells, Cell adhesion molecules, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, Leishmaniasis, Leukocyte transendothelial migration, MicroRNAs in cancer, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pertussis, Phagosome, Platelet activation, Proteoglycans in cancer, Rap1 signaling pathway, Regulation of actin cytoskeleton, Shigellosis, Small cell lung cancer, Tight junction, Toxoplasmosis, Virion - Herpesvirus, Virion - Rotavirus, Yersinia infection 💬1件: 94 💬
375Bexsero----4件: 11, 13, 62, 222 💬
376Bexsero - sospensione iniettabile - USO intramuscolare - siringa P----1件: 62 💬
377Bexsero - sospensione iniettabile - USO intramuscolare - siringa preriempita (vetro) - 0.5ML - 1 siringa preriempita CON AGO----2件: 62, 66 💬
378Bexsero meningococcal group B vaccine FOR injection IN PRE-filled syringe----1件: 222 💬
379Bexsero sospensione iniettabile IN siringa preriempita----1件: 62 💬
380Bexsero – sospensione iniettabile – siringa preriempita----2件: 61, 62 💬
381Bezafibrat genericon retard 400 MG----1件: 93 💬
382Bezafibrate1件: Bezafibrate1件: Bezafibrate 💬 1件: NR1C1 💬 10件: Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬8件: 20, 93, 94, 160, 296, 316, 324, 344 💬
383Bezafibrate (400MG) IN addition TO standard 15-20 MG/KG/jour udca therapy2件: Bezafibrate,
Ursodeoxycholic acid		2件: Ursodiol ,
Bezafibrate 💬 		2件: NR1C1,
NR1H4 💬 		11件: Adipocytokine signaling pathway, Alcoholic liver disease, Bile secretion, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬1件: 94 💬
384Bezafibrate 100 MG1件: Bezafibrate1件: Bezafibrate 💬 1件: NR1C1 💬 10件: Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬1件: 93 💬
385Bezafibrate 200 MG1件: Bezafibrate1件: Bezafibrate 💬 1件: NR1C1 💬 10件: Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬1件: 93 💬
386Bezafibrate 200 MG IN addition TO udca therapy2件: Bezafibrate,
Ursodeoxycholic acid		2件: Ursodiol ,
Bezafibrate 💬 		2件: NR1C1,
NR1H4 💬 		11件: Adipocytokine signaling pathway, Alcoholic liver disease, Bile secretion, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬1件: 93 💬
387Bezafibrate 200 MG oral tablet1件: Bezafibrate1件: Bezafibrate 💬 1件: NR1C1 💬 10件: Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬1件: 93 💬
388Bezafibrate 400 MG1件: Bezafibrate1件: Bezafibrate 💬 1件: NR1C1 💬 10件: Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬1件: 93 💬
389Bezafibrate 400 MG IN addition TO udca therapy2件: Bezafibrate,
Ursodeoxycholic acid		2件: Ursodiol ,
Bezafibrate 💬 		2件: NR1C1,
NR1H4 💬 		11件: Adipocytokine signaling pathway, Alcoholic liver disease, Bile secretion, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬1件: 93 💬
390Bezafibrate IR1件: Bezafibrate1件: Bezafibrate 💬 1件: NR1C1 💬 10件: Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬1件: 93 💬
391Bezafibrate SR1件: Bezafibrate1件: Bezafibrate 💬 1件: NR1C1 💬 10件: Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬1件: 93 💬
392Bezafibrate, beza, BZF, bezalip1件: Bezafibrate1件: Bezafibrate 💬 1件: NR1C1 💬 10件: Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬1件: 93 💬
393Bezafibrate, beza, BZF, bezalip mono1件: Bezafibrate1件: Bezafibrate 💬 1件: NR1C1 💬 10件: Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬1件: 93 💬
394Bezafilbrate IR----1件: 93 💬
395Bezalip----2件: 93, 94 💬
396Bezalip retard----1件: 160 💬
397Bezlotoxumab1件: Bezlotoxumab1件: Bezlotoxumab 💬 --2件: 96, 97 💬
398BF 2.649----1件: 6 💬
399BF 2.649 10 MG----1件: 6 💬
400BF 2.649 20 MG----1件: 6 💬
401BF 2.649 40 MG----1件: 6 💬
402BF 2.649 5 MG----1件: 6 💬
403BF2.649----1件: 6 💬
404BF8441件: BF-844---1件: 303 💬
405BG-12 120----1件: 13 💬
406BG00002----1件: 13 💬
407BG00011----1件: 85 💬
408BG00012----2件: 13, 46 💬
409BG9418----1件: 13 💬
410BG9924----2件: 46, 97 💬
411BGC20-0134----1件: 13 💬
412BGG492----1件: 13 💬
413BGJ398----1件: 238 💬
414BGP-014----1件: 97 💬
415BGP-014 capsules----1件: 97 💬
416BGX-0214----1件: 46 💬
417BH4----2件: 51, 240 💬
418BH4 20MG----1件: 299 💬
419BH4 5MG----1件: 299 💬
420BHT-3009----1件: 13 💬
421BHT-3009 0.5 MG----1件: 13 💬
422BHT-3009 1.5 MG----1件: 13 💬
423BHT-3009-01----1件: 13 💬
424BHV-0223----1件: 2 💬
425BHV-2000----1件: 3 💬
426BHV-3241----1件: 17 💬
427BHV-8000----1件: 6 💬
428BHV3241, verdiperstat----1件: 17 💬
429BI 1015550----2件: 51, 85 💬
430BI 1015550 18 MG film coated tablet----1件: 85 💬
431BI 1015550 9 MG film coated tablet----1件: 85 💬
432BI 1265162----1件: 299 💬
433BI 1265162 10 µG----1件: 299 💬
434BI 1265162 100 µG----1件: 299 💬
435BI 1265162 25 µG----1件: 299 💬
436BI 1265162 50 µG----1件: 299 💬
437BI 1291583----1件: 299 💬
438BI 1323495----1件: 299 💬
439BI 1819479----1件: 85 💬
440BI 1839100----1件: 85 💬
441BI 3720931----1件: 299 💬
442BI 443651----1件: 299 💬
443BI 655064----2件: 46, 63 💬
444BI 655064 high dose----1件: 46 💬
445BI 655064 LOW dose----1件: 46 💬
446BI 655064 medium dose----1件: 46 💬
447BI 655066----1件: 96 💬
448BI 655066 10 MG/ML----1件: 96 💬
449BI 655066 90 MG/ML----2件: 96, 271 💬
450BI 655130----3件: 37, 96, 97 💬
451BI 695500----1件: 46 💬
452BI 695501----2件: 46, 96 💬
453BI 695501 autoinjector----1件: 46 💬
454BI 695501 prefilled syringe----1件: 46 💬
455BI 705564----1件: 49 💬
456BI 706321----1件: 96 💬
457BI 730357----1件: 271 💬
458BI 764198----1件: 222 💬
459BI-peglyte----2件: 96, 97 💬
460BI655130----1件: 37 💬
461BI706321----1件: 96 💬
462BIA----1件: 6 💬
463BIA 28-6156 10 MG1件: BIA---1件: 6 💬
464BIA 28-6156 60 MG1件: BIA---1件: 6 💬
465BIA 3-2021件: BIA---1件: 6 💬
466BIA 5-10581件: BIA---1件: 86 💬
467BIA 6-5121件: BIA---1件: 6 💬
468BIA 6-512 100 MG1件: BIA---1件: 6 💬
469BIA 6-512 100 MG dose1件: BIA---1件: 6 💬
470BIA 6-512 200 MG dose1件: BIA---1件: 6 💬
471BIA 6-512 25 MG1件: BIA---1件: 6 💬
472BIA 6-512 25 MG dose1件: BIA---1件: 6 💬
473BIA 6-512 400 MG1件: BIA---1件: 6 💬
474BIA 6-512 50 MG dose1件: BIA---1件: 6 💬
475BIA 9-10671件: BIA---1件: 6 💬
476BIA 9-1067 15 MG1件: BIA---1件: 6 💬
477BIA 9-1067 25 MG1件: BIA---1件: 6 💬
478BIA 9-1067 30 MG1件: BIA---1件: 6 💬
479BIA 9-1067 5 MG1件: BIA---1件: 6 💬
480BIA 9-1067 micronized1件: BIA---1件: 6 💬
481BIA 9-1067 NON-micronized1件: BIA---1件: 6 💬
482BIA SUB-study1件: BIA---1件: 299 💬
483BIA-5-10581件: BIA---1件: 86 💬
484Biap----2件: 46, 97 💬
485Bibf 1120----2件: 51, 85 💬
486Bibf 1120 ES----1件: 85 💬
487BIBF1120----1件: 85 💬
488Bibr 796 BS----1件: 46 💬
489Bibr 796 BS, 20 MG----1件: 96 💬
490Bibr 796 BS, 5 MG----1件: 96 💬
491Bicain spinal----1件: 46 💬
492Bicarbonate ringer'S solution----1件: 296 💬
493Bicarbonato DI sodio----1件: 97 💬
494BIF195 capsules----1件: 96 💬
495Bifico----1件: 291 💬
496Bifidobacterium1件: Bifidobacterium spp.1件: Bifidobacterium 💬 --6件: 6, 35, 67, 96, 97, 271 💬
497Bifidobacterium breve2件: Bifidobacterium breve,
Bifidobacterium spp.		1件: Bifidobacterium 💬 --1件: 97 💬
498Bifidobacterium infantis 356242件: Bifidobacterium longum infantis,
Bifidobacterium spp.		1件: Bifidobacterium 💬 --2件: 96, 97 💬
499Bifidobacterium longum2件: Bifidobacterium longum,
Bifidobacterium spp.		1件: Bifidobacterium 💬 --1件: 97 💬
500BIIB014----1件: 6 💬
501BIIB017----1件: 13 💬
502BIIB017 (peginterferon BETA-1A) autoinjector1件: Peginterferon beta-1a1件: Peginterferon beta-1a 💬 2件: IFNAR1,
IFNAR2 💬 		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
503BIIB019----1件: 13 💬
504BIIB023----1件: 46 💬
505BIIB033----1件: 13 💬
506BIIB033 (ANTI-lingo) - EV substance code SUB118957----1件: 13 💬
507BIIB041----1件: 13 💬
508BIIB050 / KNS-760704----1件: 2 💬
509BIIB050/KNS-760704----1件: 2 💬
510BIIB054----1件: 6 💬
511BIIB057----1件: 46 💬
512BIIB059----1件: 49 💬
513BIIB061----1件: 13 💬
514BIIB067----1件: 2 💬
515BIIB067 (ISIS666853)----1件: 2 💬
516BIIB067, qalsody1件: Tofersen1件: Tofersen 💬 1件: SOD1 💬 8件: Amyotrophic lateral sclerosis, Chemical carcinogenesis - reactive oxygen species, Huntington disease, Longevity regulating pathway - multiple species, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Peroxisome, Prion disease 💬1件: 2 💬
517BIIB078----1件: 2 💬
518BIIB091----1件: 13 💬
519BIIB092----3件: 5, 7, 127 💬
520BIIB094----1件: 6 💬
521BIIB100----1件: 2 💬
522BIIB105----1件: 2 💬
523BIIB111----1件: 90 💬
524BIIB1121件: Cotoretigene toliparvovec---1件: 90 💬
525BIIB1151件: BIIB115---1件: 3 💬
526BIIB122----1件: 6 💬
527BIIB122 225 MG----1件: 6 💬
528BIIB133----1件: 13 💬
529Biil 284 BS high dose----1件: 46 💬
530Biil 284 BS LOW dose----1件: 46 💬
531Biil 284 BS medium dose----1件: 46 💬
532Biil 284 BS, high dose----1件: 299 💬
533Biil 284 BS, high dose, adult patients----1件: 299 💬
534Biil 284 BS, high dose, pediatric patients----1件: 299 💬
535Biil 284 BS, LOW dose----1件: 299 💬
536Biil 284 BS, LOW dose, adult patients----1件: 299 💬
537Biil 284 BS, LOW dose, pediatric patients----1件: 299 💬
538Biil 284 BS, medium dose, adult patients----1件: 299 💬
539Biil 284 BS, medium dose, pediatric patients----1件: 299 💬
540Bilateral high frequency deep brain stimulation OF THE subthalamic neucleus combined with best medical treatment according TO widely accepted expert consensus paper----1件: 6 💬
541Bilateral high frequency deep brainstimulation OF THE subthalamic nucleus combined with best medical treatment----1件: 6 💬
542Bilateral surgical infusion OF AAV-GAD into THE subthalamic nucleus----1件: 6 💬
543Bilateral transforaminal epidural steroid injections----1件: 70 💬
544Biliary stent----1件: 300 💬
545BIM 23014----1件: 67 💬
546BIM 23a760----1件: 77 💬
547BIM23a760----1件: 77 💬
548BIM23b065----1件: 77 💬
549Bimagrumab1件: Bimagrumab1件: Bimagrumab 💬 2件: ACVR2A,
ACVR2B 💬 		4件: Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Signaling pathways regulating pluripotency of stem cells, TGF-beta signaling pathway 💬1件: 15 💬
550Bimekizumab1件: Bimekizumab1件: Bimekizumab 💬 2件: IL17A,
IL17F 💬 		6件: Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬5件: 37, 46, 97, 107, 271 💬
551Binimetinib1件: Binimetinib1件: Binimetinib 💬 2件: MAP2K1,
MAP2K2 💬 		88件: Acute myeloid leukemia, Alcoholism, Alzheimer disease, Apelin signaling pathway, Apoptosis, Autophagy - animal, B cell receptor signaling pathway, Bladder cancer, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Cushing syndrome, Efferocytosis, Endometrial cancer, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, Insulin signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Long-term depression, Long-term potentiation, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-small cell lung cancer, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Serotonergic synapse, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Thyroid cancer, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, VEGF signaling pathway, Vascular smooth muscle contraction, Yersinia infection, cAMP signaling pathway, cGMP-PKG signaling pathway, mTOR signaling pathway 💬1件: 34 💬
552Binocrit*1SIR 40000UI/1ML1件: Erythropoietin4件: Epoetin alfa ,
Epoetin epsilon ,
Epoetin theta ,
Epoetin zeta 💬 		1件: EPOR 💬 7件: Cytokine-cytokine receptor interaction, Efferocytosis, Hematopoietic cell lineage, Hormone signaling, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬1件: 18 💬
553Binyrebarkhormon----1件: 46 💬
554Binyrebsrkhormon----1件: 46 💬
555BIO-25 probiotic----1件: 299 💬
556BIO-enhanced curcumin soft gelatin capsule----1件: 97 💬
557BIO-kult advanced----1件: 66 💬
558BIO101----1件: 113 💬
559Bioactive glass-ceramic spacer----1件: 70 💬
560Biobanking with genetic analysis----3件: 13, 51, 56 💬
561Biocarn----1件: 3 💬
562Biocollection----1件: 3 💬
563Biodex balance system----1件: 6 💬
564Biodmards----1件: 46 💬
565Bioelectrical impedance analysis----1件: 172 💬
566Biofluid samplings----1件: 6 💬
567Biologic agents----1件: 46 💬
568Biologic dmards----1件: 107 💬
569Biologic or targeted synthetic dmard----2件: 46, 271 💬
570Biologic tnfi----1件: 46 💬
571Biologic/targeted therapy----1件: 46 💬
572Biological agents----2件: 46, 96 💬
573Biological assays----1件: 19 💬
574Biological assessment----1件: 61 💬
575Biological dmards----2件: 86, 107 💬
576Biological drug----4件: 46, 96, 97, 107 💬
577Biological NTLA-2002----1件: 65 💬
578Biological NTLA-3001----1件: 231 💬
579Biological samples----2件: 13, 206 💬
580Biological sampling----2件: 65, 97 💬
581Biological samplings----1件: 96 💬
582Biological/vaccine: allogeneic HB-admscs----1件: 6 💬
583Biological: etanercept and ITS biosimilars----1件: 271 💬
584Biological: M254----1件: 63 💬
585Biological: mesenchymal stem cell----1件: 93 💬
586Biological: SM03----1件: 46 💬
587Biological: umbilical cord based allogenic mesenchymal stem cell----1件: 113 💬
588Biologically active human fecal material, openbiome----1件: 97 💬
589Biologically active human fecal microbiota----1件: 97 💬
590Biologics----4件: 46, 96, 97, 271 💬
591Biomarker identification IN parkinson disease----1件: 6 💬
592BION-1301----1件: 66 💬
593BION-1301 multiple doses----1件: 66 💬
594BION-1301 single dose----1件: 66 💬
595Bionetide----1件: 156 💬
596Bioopa dressing----1件: 36 💬
597Biopsy----6件: 28, 34, 51, 65, 193, 285 💬
598Biopsy OF colon----1件: 97 💬
599Biopsy OF THE labial salivary gland----1件: 53 💬
600Biopsy procedure----1件: 65 💬
601Biosimilar----4件: 46, 96, 97, 271 💬
602Biosimilar adalimumab1件: Adalimumab1件: Adalimumab 💬 1件: TNF 💬 66件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 107 💬
603Biosimilar etanercept1件: Etanercept1件: Etanercept 💬 2件: LTA,
TNF 💬 		66件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 107 💬
604Biosimilar infliximab1件: Infliximab1件: Infliximab 💬 1件: TNF 💬 66件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬3件: 46, 96, 97 💬
605Biosimilar product TO adalimumab1件: Adalimumab1件: Adalimumab 💬 1件: TNF 💬 66件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
606Biospecimen collection----18件: 13, 26, 28, 34, 46, 49, 50, 51, 53, 60, 62, 65, 96, 97, 159, 284, 285, 286 💬
607Biostamp npoint device----1件: 8 💬
608Biostate----1件: 288 💬
609Biotherapy prescription with sinnotest® software----1件: 46 💬
610Biotin1件: Biotin1件: Biotin 💬 --3件: 2, 8, 13 💬
611Biotina1件: Biotin1件: Biotin 💬 --1件: 8 💬
612Birb 796 BS, high dose----1件: 46 💬
613Birb 796 BS, LOW dose----1件: 46 💬
614Birch bark extract1件: Birch bark extract1件: Birch triterpenes 💬 --1件: 36 💬
615Birt 2584 XX----1件: 13 💬
616Birt 2584XX----1件: 13 💬
617Birtamimab1件: Birtamimab1件: Birtamimab 💬 --1件: 28 💬
618BIS-choline tetrathiomolybdate----1件: 171 💬
619BIS-choline tetrathiomolybdate, BIS[(2-hydroxyethyl)trimethylammonium] tetrathiomolybdate----1件: 171 💬
620Bisacodyl1件: Bisacodyl1件: Bisacodyl 💬 --2件: 13, 97 💬
621Bisoprolol1件: Bisoprolol2件: Bisoprolol fumarate ,
Bisoprolol 💬 		1件: ADRB1 💬 13件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬4件: 58, 67, 86, 113 💬
622Bisoprolol fumarate1件: Bisoprolol2件: Bisoprolol fumarate ,
Bisoprolol 💬 		1件: ADRB1 💬 13件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 113 💬
623Bisphosphonate----1件: 274 💬
624Bisphosphonate treatment----2件: 113, 299 💬
625Bisphosphonates----2件: 6, 274 💬
626Bitopertin1件: Bitopertin1件: Bitopertin 💬 1件: SLC6A5_9 💬 2件: Neuroactive ligand signaling, Synaptic vesicle cycle 💬1件: 284 💬
627Bitter candytuft fresh plant extract----1件: 97 💬
628Bitterschleifenblume-ganzpflanze 1,5ML/10ML----1件: 97 💬
629BIV009----2件: 61, 162 💬
630Bivigam----1件: 65 💬
631BIVV009----1件: 61 💬
632BIVV020----2件: 14, 61 💬
633BL-7040----1件: 97 💬
634BL-8040----1件: 60 💬
635Bladder instillation----1件: 226 💬
636Bladder instillation with heparin/ lidocaine----1件: 226 💬
637Bladder instillation with triamcinolone acetonide----1件: 226 💬
638Bladder instillation without triamcinolone acetonide----1件: 226 💬
639Bladder instillations----1件: 226 💬
640Bladder tissue OF interstitial cystitis and normal bladder tissue----1件: 226 💬
641Blarcamesine1件: Blarcamesine2件: Blarcamesine ,
Blarcamesine hydrochloride 💬 		6件: CHRM1,
CHRM2,
CHRM3,
CHRM4,
CHRM5,
SIGMAR1 💬 		15件: Alzheimer disease, Amyotrophic lateral sclerosis, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬1件: 156 💬
642BLD-04091件: Cudetaxestat---1件: 85 💬
643BLD-2660----1件: 85 💬
644Bleomycin1件: Bleomycin3件: Bleomycin sulfate ,
Bleomycin hydrochloride ,
Bleomycin 💬 		--3件: 96, 278, 280 💬
645Bleomycin + fibrovein1件: Bleomycin3件: Bleomycin sulfate ,
Bleomycin hydrochloride ,
Bleomycin 💬 		--1件: 279 💬
646Bleomycin baxter1件: Bleomycin3件: Bleomycin sulfate ,
Bleomycin hydrochloride ,
Bleomycin 💬 		--1件: 279 💬
647Bleselumab1件: Bleselumab1件: Bleselumab 💬 1件: TNFRSF5 💬 17件: Allograft rejection, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Human T-cell leukemia virus 1 infection, Intestinal immune network for IgA production, Lipid and atherosclerosis, Malaria, NF-kappa B signaling pathway, Primary immunodeficiency, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Viral myocarditis 💬1件: 222 💬
648BLF----1件: 299 💬
649BLI-1300 high dose----1件: 96 💬
650BLI-1300 LOW dose----1件: 96 💬
651Blinatumomab1件: Blinatumomab1件: Blinatumomab 💬 4件: CD19,
CD3D,
CD3E,
CD3G 💬 		13件: B cell receptor signaling pathway, Chagas disease, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Primary immunodeficiency, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬3件: 11, 46, 49 💬
652Blinatumomab 9UG1件: Blinatumomab1件: Blinatumomab 💬 4件: CD19,
CD3D,
CD3E,
CD3G 💬 		13件: B cell receptor signaling pathway, Chagas disease, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Primary immunodeficiency, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬1件: 49 💬
653Blinded cdca 250 MG TID1件: Chenodeoxycholic acid1件: Chenodiol 💬 1件: NR1H4 💬 1件: Bile secretion 💬1件: 263 💬
654Blisibimod1件: Blisibimod1件: Blisibimod 💬 --5件: 43, 44, 49, 63, 66 💬
655Blisibimod injection1件: Blisibimod1件: Blisibimod 💬 --1件: 66 💬
656Blokium 50 MG comprimidos----1件: 167 💬
657Blood analysis----1件: 6 💬
658Blood analysis FOR frataxin'S level measurement----1件: 18 💬
659Blood analysis FOR hypercalcemia'S control----1件: 18 💬
660Blood and fecal samples----2件: 96, 97 💬
661Blood and nasal swab sampling----1件: 137 💬
662Blood and stools samples----1件: 96 💬
663Blood and urine sampling----1件: 195 💬
664Blood and/or skin biopsy----2件: 90, 301 💬
665Blood assays----1件: 113 💬
666Blood coagulation factor viii and VWF, human----1件: 288 💬
667Blood coagulation factor xiii----1件: 51 💬
668Blood collection----2件: 229, 271 💬
669Blood draw----7件: 6, 19, 65, 67, 96, 231, 299 💬
670Blood draw FOR optional genetic exome sequencing----3件: 3, 15, 256 💬
671Blood draw FOR THE laboratory assessment----2件: 94, 303 💬
672Blood drawing----1件: 21 💬
673Blood drawing IN healthy controls----1件: 65 💬
674Blood drawing IN patients with WAS----1件: 65 💬
675Blood drawing only group C----1件: 49 💬
676Blood glucose results----1件: 299 💬
677Blood or saliva sample collection----3件: 96, 97, 299 💬
678Blood parameters----1件: 164 💬
679Blood sample----28件: 2, 3, 8, 13, 34, 46, 49, 51, 53, 61, 65, 66, 67, 84, 88, 96, 97, 107, 113, 127, 195, 206, 235, 274, 280, 288, 294, 299 💬
680Blood sample and cotton skin swabs----1件: 162 💬
681Blood sample and environmental survey----1件: 2 💬
682Blood sample collection----1件: 85 💬
683Blood samples----12件: 13, 41, 46, 51, 61, 96, 97, 167, 227, 240, 271, 280 💬
684Blood samples collect----1件: 234 💬
685Blood samples FOR ANTI-drug antibodies----1件: 28 💬
686Blood samples FOR immunoglobulins----1件: 28 💬
687Blood samples FOR inflammatory markers----1件: 28 💬
688Blood sampling----9件: 13, 17, 46, 49, 51, 96, 98, 106, 162 💬
689Blood sampling and DNA collection----1件: 6 💬
690Blood sampling FOR biological and genetic analysis----1件: 19 💬
691Blood sampling from infant----3件: 46, 96, 271 💬
692Blood sampling from mother----3件: 46, 96, 271 💬
693Blood sampling from umbilical cord----3件: 46, 96, 271 💬
694Blood sampling, endoscopy----1件: 97 💬
695Blood test 4 edta tubes----1件: 97 💬
696Blood tests----3件: 13, 46, 263 💬
697Blood tests: IGF-1, AST/ALT/ALP/tbil, GTT----1件: 77 💬
698Blood withdrawal----1件: 48 💬
699Blood-flow restricted training----1件: 15 💬
700Bloodsampling----1件: 167 💬
701BLS-M221件: BLS-M22---1件: 113 💬
702Blue light photopheresis----1件: 96 💬
703Blue light-absorbing sunglasses----1件: 90 💬
704Blueberry-rich diet1件: Blueberry---2件: 96, 97 💬
705BLZ945----1件: 2 💬
706BM110----1件: 19 💬
707BMB-101----2件: 140, 144 💬
708Bmdex----1件: 28 💬
709BMI and lean mass index from DXA----1件: 299 💬
710Bmmnc----1件: 13 💬
711Bmmncs----1件: 90 💬
712BMN 0441件: BMN-044---1件: 113 💬
713BMN 044 IV 6 MG/KG1件: BMN-044---1件: 113 💬
714BMN 044 IV 9 MG/KG1件: BMN-044---1件: 113 💬
715BMN 044 SC 6 MG/KG1件: BMN-044---1件: 113 💬
716BMN 0451件: BMN-045---1件: 113 💬
717BMN 053----1件: 113 💬
718BMN 110----1件: 19 💬
719BMN 110 - every other week----1件: 19 💬
720BMN 110 - weekly----1件: 19 💬
721BMN 110 every other week----1件: 19 💬
722BMN 110 weekly----1件: 19 💬
723BMN 111----1件: 276 💬
724BMN 111 administration VIA injector PEN----1件: 276 💬
725BMN 111 administration VIA vial and syringe----1件: 276 💬
726BMN 165----1件: 240 💬
727BMN 190----1件: 19 💬
728BMN 250----1件: 19 💬
729BMN 307----1件: 240 💬
730BMN 349----1件: 231 💬
731BMN 351----1件: 113 💬
732BMN 701----1件: 256 💬
733BMN0531件: BMN-053---1件: 113 💬
734BMN165 20MG/DAY----1件: 240 💬
735BMN165 40MG/DAY----1件: 240 💬
736BMS-188667----10件: 46, 49, 53, 65, 96, 97, 107, 160, 222, 271 💬
737BMS-232632----1件: 265 💬
738BMS-5829491件: BMS-582949---1件: 46 💬
739BMS-582949 and methotrexate1件: BMS-582949---1件: 46 💬
740BMS-8173991件: BMS-817399---1件: 46 💬
741BMS-9316991件: Lulizumab pegol---3件: 49, 53, 160 💬
742BMS-936557----2件: 96, 97 💬
743BMS-9454291件: Clazakizumab1件: Clazakizumab 💬 --2件: 46, 96 💬
744BMS-986004----1件: 63 💬
745BMS-986004 1500 MG IV----1件: 63 💬
746BMS-986004 225 MG IV----1件: 63 💬
747BMS-986004 675 MG IV----1件: 63 💬
748BMS-986004 75 MG IV----1件: 63 💬
749BMS-9860201件: BMS-986020---2件: 51, 85 💬
750BMS-986089-01 (RO7239361) , ANTI-myostatin----1件: 113 💬
751BMS-986089-01 (RO7239361), ANTI-myostatin----1件: 113 💬
752BMS-986089-01, ANTI-myostatin----1件: 113 💬
753BMS-9861041件: BMS-986104---1件: 46 💬
754BMS-9861421件: BMS-986142---3件: 46, 53, 160 💬
755BMS-986142 200MG1件: BMS-986142---1件: 46 💬
756BMS-986142 350MG1件: BMS-986142---1件: 46 💬
757BMS-986165----3件: 49, 96, 97 💬
758BMS-986165 capsule----1件: 49 💬
759BMS-986165 tablet----1件: 49 💬
760BMS-986166----1件: 97 💬
761BMS-9861681件: Gosuranemab1件: Gosuranemab 💬 1件: MAPT 💬 4件: Alzheimer disease, MAPK signaling pathway, Parkinson disease, Pathways of neurodegeneration - multiple diseases 💬1件: 5 💬
762BMS-986184----1件: 97 💬
763BMS-9861951件: Branebrutinib1件: Branebrutinib 💬 1件: BTK 💬 7件: B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬3件: 46, 49, 53 💬
764BMS-9862511件: BMS-986251---2件: 46, 271 💬
765BMS-986256-06, TLR7/8 antagonist1件: Afimetoran1件: Afimetoran 💬 --1件: 49 💬
766BMS-9862781件: BMS-986278---1件: 85 💬
767BMS-986325----1件: 53 💬
768BMS-986326----1件: 49 💬
769BMS-986368----1件: 13 💬
770BMS-986374----1件: 13 💬
771BMS-986413----1件: 64 💬
772BMS-986414----1件: 64 💬
773BMS-9894923----1件: 6 💬
774BMS188667----1件: 46 💬
775BMS356384----1件: 79 💬
776BMS986142----3件: 46, 53, 160 💬
777BMS986165----2件: 96, 97 💬
778BMS986168----1件: 5 💬
779BMS986195----3件: 46, 49, 53 💬
780BN82451B----1件: 8 💬
781BN8251B----1件: 8 💬
782BNJ441----1件: 66 💬
783BNP blood sample test----1件: 58 💬
784BNT162----1件: 13 💬
785BNT162b2, bivalent----7件: 13, 35, 46, 49, 50, 51, 107 💬
786Bocidelpar1件: Bocidelpar2件: Bocidelpar ,
Bocidelpar sulfate 💬 		1件: NR1C3 💬 12件: AMPK signaling pathway, Efferocytosis, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬1件: 113 💬
787Body composition----1件: 67 💬
788Body composition using A HAND-held body FAT monitor • resting metabolic rate (RMR) using A ventilated hood system----1件: 8 💬
789Bodybio balance OIL----1件: 13 💬
790Bodybio PC----1件: 13 💬
791BOF-, mazelen-, rubellavaccin, poeder voor injectievloeistof----1件: 107 💬
792Bone balance measurements----1件: 81 💬
793Bone densitometry----2件: 49, 162 💬
794Bone marrow ablation with stem cell support----2件: 28, 60 💬
795Bone marrow aspirate----1件: 60 💬
796Bone marrow aspiration----8件: 2, 28, 60, 62, 65, 284, 285, 286 💬
797Bone marrow aspiration and biopsy----3件: 28, 34, 60 💬
798Bone marrow autologous mesenchymal stem cells transplantation----1件: 13 💬
799Bone marrow biopsy----7件: 26, 28, 60, 62, 65, 284, 286 💬
800Bone marrow cell transplantation----1件: 274 💬
801Bone marrow concentrate----1件: 70 💬
802Bone marrow derived mesenchymal stem cells----2件: 6, 60 💬
803Bone marrow infusion----1件: 36 💬
804Bone marrow mesenchymal stem cells----1件: 85 💬
805Bone marrow mononuclear cells----1件: 57 💬
806Bone marrow or umbilical cord blood (UCG) stem cell transplantation----1件: 36 💬
807Bone marrow transplant----2件: 60, 274 💬
808Bone marrow transplantation----4件: 51, 60, 284, 285 💬
809Bone marrow-derived mesenchymal stem cells----1件: 298 💬
810Bone mineral density (dexa) scan----1件: 98 💬
811Bonefos----1件: 274 💬
812BONT-A----1件: 6 💬
813Bony toxicity----1件: 34 💬
814Bood and urine sampling----1件: 265 💬
815Boost cells----1件: 274 💬
816Boost VHC----1件: 299 💬
817Boots high strength garlic odour controlled----1件: 299 💬
818Borage OIL 20% GLA1件: Borage oil---1件: 13 💬
819Borg scale----3件: 3, 15, 256 💬
820Bortezomib2件: Bortezomib,
Bortezomib D-mannitol		1件: Bortezomib 💬 1件: PSMB5 💬 8件: Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬16件: 11, 13, 26, 28, 46, 49, 51, 61, 63, 66, 172, 222, 228, 256, 288, 331 💬
821Bortezomib accord2件: Bortezomib,
Bortezomib D-mannitol		1件: Bortezomib 💬 1件: PSMB5 💬 8件: Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬1件: 28 💬
822Bortezomib D-mannitol2件: Bortezomib,
Bortezomib D-mannitol		1件: Bortezomib 💬 1件: PSMB5 💬 8件: Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬1件: 28 💬
823Bortezomib injection1件: Bortezomib1件: Bortezomib 💬 1件: PSMB5 💬 8件: Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬1件: 64 💬
824Bortezomib/dexamethasone1件: Bortezomib1件: Bortezomib 💬 1件: PSMB5 💬 8件: Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬1件: 283 💬
825Bortezomib/dexamethasone (BD), followed BY autologous STC & maintenance bortezomib/dexamethasone1件: Bortezomib1件: Bortezomib 💬 1件: PSMB5 💬 8件: Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬1件: 28 💬
826BOS161721----1件: 49 💬
827Bosentan1件: Bosentan2件: Bosentan ,
Bosentan 💬 		2件: EDNRA,
EDNRB 💬 		9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬11件: 40, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬
828Bosentan 125 MG1件: Bosentan2件: Bosentan ,
Bosentan 💬 		2件: EDNRA,
EDNRB 💬 		9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 51 💬
829Bosentan 62.5 MG1件: Bosentan2件: Bosentan ,
Bosentan 💬 		2件: EDNRA,
EDNRB 💬 		9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 51 💬
830Bosentan administration1件: Bosentan2件: Bosentan ,
Bosentan 💬 		2件: EDNRA,
EDNRB 💬 		9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 86 💬
831Bosentan dispersible tablets1件: Bosentan2件: Bosentan ,
Bosentan 💬 		2件: EDNRA,
EDNRB 💬 		9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 86 💬
832Bosentan group1件: Bosentan2件: Bosentan ,
Bosentan 💬 		2件: EDNRA,
EDNRB 💬 		9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 51 💬
833Bosentan monohydrat1件: Bosentan2件: Bosentan ,
Bosentan 💬 		2件: EDNRA,
EDNRB 💬 		9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 86 💬
834Bosentan monohydrate1件: Bosentan2件: Bosentan ,
Bosentan 💬 		2件: EDNRA,
EDNRB 💬 		9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬4件: 51, 84, 86, 88 💬
835Bosentan mylan1件: Bosentan2件: Bosentan ,
Bosentan 💬 		2件: EDNRA,
EDNRB 💬 		9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 41 💬
836Bosentan, ambrisentan1件: Bosentan2件: Bosentan ,
Bosentan 💬 		2件: EDNRA,
EDNRB 💬 		9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 86 💬
837Bosutinib1件: Bosutinib2件: Bosutinib ,
Bosutinib hydrate 💬 		2件: ABL1,
SRC 💬 		48件: Adherens junction, Axon guidance, Bacterial invasion of epithelial cells, Bladder cancer, C-type lectin receptor signaling pathway, Cell cycle, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Chronic myeloid leukemia, Endocytosis, Epithelial cell signaling in Helicobacter pylori infection, ErbB signaling pathway, Estrogen signaling pathway, Fluid shear stress and atherosclerosis, Focal adhesion, GABAergic synapse, Gap junction, GnRH signaling pathway, Hepatitis B, Herpes simplex virus 1 infection, Hormone signaling, Human cytomegalovirus infection, Inflammatory mediator regulation of TRP channels, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, MicroRNAs in cancer, Mitophagy - animal, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Oxytocin signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Platelet activation, Prolactin signaling pathway, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis, Thyroid hormone signaling pathway, Tight junction, Tuberculosis, VEGF signaling pathway, Viral carcinogenesis, Viral myocarditis, Yersinia infection 💬2件: 2, 67 💬
838Boswelan----1件: 13 💬
839Boswellia serrata extract PS0201BO capsules1件: Indian frankincense---1件: 13 💬
840Botaretigene sparoparvovec1件: Botaretigene sparoparvovec---1件: 90 💬
841Botox1件: Botulinum toxin type A2件: Botulinum toxin type A ,
Prabotulinumtoxin A 💬 		1件: SNAP25 💬 2件: Insulin secretion, Synaptic vesicle cycle 💬5件: 6, 13, 36, 149, 226 💬
842Botox 100 UNT injection----1件: 13 💬
843Botox 100U IN normal saline----1件: 226 💬
844Botox 200U IN normal saline----1件: 226 💬
845Botox injection----2件: 2, 47 💬
846Botox® solution----1件: 51 💬
847Botulinic toxin----1件: 36 💬
848Botulinum A toxin----1件: 118 💬
849Botulinum toxin----3件: 6, 13, 149 💬
850Botulinum toxin A1件: Botulinum toxin type A2件: Botulinum toxin type A ,
Prabotulinumtoxin A 💬 		1件: SNAP25 💬 2件: Insulin secretion, Synaptic vesicle cycle 💬4件: 13, 51, 149, 226 💬
851Botulinum toxin A - haemagglutinin complex1件: Botulinum toxin type A2件: Botulinum toxin type A ,
Prabotulinumtoxin A 💬 		1件: SNAP25 💬 2件: Insulin secretion, Synaptic vesicle cycle 💬1件: 13 💬
852Botulinum toxin type A1件: Botulinum toxin type A2件: Botulinum toxin type A ,
Prabotulinumtoxin A 💬 		1件: SNAP25 💬 2件: Insulin secretion, Synaptic vesicle cycle 💬11件: 2, 5, 6, 7, 13, 15, 17, 47, 113, 149, 171 💬
853Botulinum toxin type A (nabota®) injection into THE gastrocnemius muscle1件: Botulinum toxin type A2件: Botulinum toxin type A ,
Prabotulinumtoxin A 💬 		1件: SNAP25 💬 2件: Insulin secretion, Synaptic vesicle cycle 💬1件: 70 💬
854Botulinum toxin type A 200U1件: Botulinum toxin type A2件: Botulinum toxin type A ,
Prabotulinumtoxin A 💬 		1件: SNAP25 💬 2件: Insulin secretion, Synaptic vesicle cycle 💬1件: 13 💬
855Botulinum toxin type A 300U1件: Botulinum toxin type A2件: Botulinum toxin type A ,
Prabotulinumtoxin A 💬 		1件: SNAP25 💬 2件: Insulin secretion, Synaptic vesicle cycle 💬1件: 13 💬
856Botulinum toxin type A injection1件: Botulinum toxin type A2件: Botulinum toxin type A ,
Prabotulinumtoxin A 💬 		1件: SNAP25 💬 2件: Insulin secretion, Synaptic vesicle cycle 💬1件: 6 💬
857Botulinum toxin type B1件: Botulinum toxin type B1件: Rimabotulinumtoxin B 💬 1件: SNAP25 💬 2件: Insulin secretion, Synaptic vesicle cycle 💬3件: 2, 6, 51 💬
858Botulinum toxin: xeomin----1件: 6 💬
859Botulism toxin treatment----1件: 161 💬
860Bouchard belgian dark chocolate probiotic napolitains, containing bifidobacterium longum----1件: 13 💬
861Boulardii----2件: 96, 97 💬
862BOW015----1件: 46 💬
863Boya ivig----1件: 65 💬
864BPA----1件: 88 💬
865Bpan patients----1件: 121 💬
866BPN14770----1件: 206 💬
867BPN14770/ zatolmilast----1件: 206 💬
868BPR277----1件: 160 💬
869BPR277 ointment----1件: 160 💬
870BPS-314D-MR----1件: 86 💬
871BPS-MR----1件: 86 💬
872BPS804----2件: 172, 274 💬
873BPS804, UX143----1件: 274 💬
874BPX-501 cells----3件: 60, 285, 326 💬
875BPX-501 T cells----4件: 65, 284, 285, 326 💬
876BQ123----1件: 17 💬
877BR-DIM----1件: 49 💬
878BR9001----1件: 46 💬
879BR900A----1件: 46 💬
880Brain mpet----1件: 6 💬
881Brain MRI----3件: 8, 25, 229 💬
882Brain MRI with resting state scan----1件: 6 💬
883Brain MRI/MRS/fmri----1件: 19 💬
884Brain natriuretic peptide1件: .gamma.-brain natriuretic peptide---1件: 215 💬
885Brain PET scan----3件: 5, 7, 127 💬
886Bramicil - 100 MG/ 2 ML soluzione iniettabile 10 fiale DA 2 ML----1件: 299 💬
887Bramitob----1件: 299 💬
888Bramitob 300MG/4ML nebuliser solution----1件: 299 💬
889Bramitob*nebul 28F 300MG/4ML----1件: 299 💬
890Bramitob*nebul 56F 300MG/4ML----1件: 299 💬
891Bramitob® administered BY pari eflow® rapid electronic nebulizer----1件: 299 💬
892Bramitob® administered BY pari LC® plus nebulizer----1件: 299 💬
893Branaplam1件: Branaplam1件: Branaplam 💬 --2件: 3, 8 💬
894Branebrutinib1件: Branebrutinib1件: Branebrutinib 💬 1件: BTK 💬 7件: B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬3件: 46, 49, 53 💬
895Brazikumab1件: Brazikumab1件: Brazikumab 💬 1件: IL23A 💬 9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬2件: 96, 97 💬
896Brazikumab high dose1件: Brazikumab1件: Brazikumab 💬 1件: IL23A 💬 9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬1件: 96 💬
897Brazikumab induction dose1件: Brazikumab1件: Brazikumab 💬 1件: IL23A 💬 9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬2件: 96, 97 💬
898Brazikumab IV infusion1件: Brazikumab1件: Brazikumab 💬 1件: IL23A 💬 9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬1件: 96 💬
899Brazikumab LOW dose1件: Brazikumab1件: Brazikumab 💬 1件: IL23A 💬 9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬1件: 96 💬
900Brazikumab maintenance dose1件: Brazikumab1件: Brazikumab 💬 1件: IL23A 💬 9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬2件: 96, 97 💬
901Brazikumab SC injection1件: Brazikumab1件: Brazikumab 💬 1件: IL23A 💬 9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬1件: 96 💬
902Break IN L-carnitine treatment----1件: 316 💬
903Breast milk sampling----4件: 46, 96, 97, 271 💬
904Breath test----1件: 285 💬
905Breath test using THE compact PTR-TOF-MS----2件: 89, 299 💬
906Breathing exercises----1件: 6 💬
907Bredinin tablet 150MG1件: Mizoribine1件: Mizoribine 💬 2件: IMPDH,
IMPDH 💬 		2件: Drug metabolism - other enzymes, Purine metabolism 💬1件: 46 💬
908Bredinin tablet 50MG1件: Mizoribine1件: Mizoribine 💬 2件: IMPDH,
IMPDH 💬 		2件: Drug metabolism - other enzymes, Purine metabolism 💬1件: 46 💬
909Breelib nebulizer----1件: 86 💬
910Brensocatib1件: Brensocatib1件: Brensocatib 💬 1件: CTSC 💬 2件: Apoptosis, Lysosome 💬1件: 299 💬
911Brensocatib 10 MG1件: Brensocatib1件: Brensocatib 💬 1件: CTSC 💬 2件: Apoptosis, Lysosome 💬1件: 299 💬
912Brensocatib 25 MG1件: Brensocatib1件: Brensocatib 💬 1件: CTSC 💬 2件: Apoptosis, Lysosome 💬1件: 299 💬
913Brentuximab vedotin1件: Brentuximab vedotin1件: Brentuximab vedotin 💬 10件: TNFRSF8,
TUBB,
TUBB,
TUBB,
TUBB,
TUBB,
TUBB,
TUBB,
TUBB,
TUBB 💬 		12件: Alzheimer disease, Amyotrophic lateral sclerosis, Cytokine-cytokine receptor interaction, Gap junction, Huntington disease, Motor proteins, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Prion disease, Salmonella infection 💬2件: 49, 51 💬
914Brepocitinib----2件: 49, 50 💬
915Brepocitinib 25 MG----2件: 96, 97 💬
916Brepocitinib 5 MG----2件: 96, 97 💬
917Brepocitinib 5MG----1件: 96 💬
918Brief pain inventory questionnaire----1件: 19 💬
919Brief pain inventory short-form----1件: 113 💬
920Brief resilient coping scale----1件: 46 💬
921Brigatinib1件: Brigatinib1件: Brigatinib 💬 1件: ALK 💬 3件: Non-small cell lung cancer, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways in cancer 💬1件: 34 💬
922Brimonidine tartrate1件: Brimonidine2件: Brimonidine tartrate ,
Brimonidine 💬 		3件: ADRA2A,
ADRA2B,
ADRA2C 💬 		4件: Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬1件: 13 💬
923Brimonidine tartrate posterior segment drug delivery system (brimo PS DDS) applicator system1件: Brimonidine2件: Brimonidine tartrate ,
Brimonidine 💬 		3件: ADRA2A,
ADRA2B,
ADRA2C 💬 		4件: Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬1件: 90 💬
924Brineura1件: Cerliponase alfa1件: Cerliponase alfa 💬 1件: TPP1 💬 1件: Lysosome 💬1件: 19 💬
925Brintellix - 20 MG/ML - gocce orali, soluzione - USO orale - flacone (vetro) 15 ML - 1 flacone1件: Vortioxetine2件: Vortioxetine ,
Vortioxetine hydrobromide 💬 		7件: HTR1,
HTR3,
HTR3,
HTR3,
HTR3,
HTR3,
SLC6A4 💬 		6件: Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle, Taste transduction, cAMP signaling pathway 💬1件: 6 💬
926Brisk walking and balance training----1件: 6 💬
927Brivaracetam1件: Brivaracetam1件: Brivaracetam 💬 1件: SV2 💬 1件: ECM-receptor interaction 💬2件: 149, 309 💬
928Brivaracetam 25 MG1件: Brivaracetam1件: Brivaracetam 💬 1件: SV2 💬 1件: ECM-receptor interaction 💬1件: 309 💬
929Brivaracetam 50 MG1件: Brivaracetam1件: Brivaracetam 💬 1件: SV2 💬 1件: ECM-receptor interaction 💬1件: 309 💬
930BRL-049653----1件: 46 💬
931BRL-301----3件: 49, 51, 53 💬
932Broccoli1件: Broccoli---1件: 97 💬
933Broccoli sprouts1件: Broccoli---1件: 299 💬
934Brodalumab1件: Brodalumab1件: Brodalumab 💬 1件: IL17RA 💬 3件: Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway 💬2件: 37, 51 💬
935Brodalumab 210MG SC1件: Brodalumab1件: Brodalumab 💬 1件: IL17RA 💬 3件: Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway 💬1件: 37 💬
936Bromlein----2件: 94, 97 💬
937Bromocriptin 2.5MG, 2-3 times A DAY----1件: 74 💬
938Bromocriptine1件: Bromocriptine2件: Bromocriptine mesylate ,
Bromocriptine 💬 		2件: DRD2,
PRL 💬 		14件: Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway 💬2件: 6, 74 💬
939Bromocriptine and other dopamine agonists1件: Bromocriptine2件: Bromocriptine mesylate ,
Bromocriptine 💬 		2件: DRD2,
PRL 💬 		14件: Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
940Bromure D'ipratropium----1件: 86 💬
941Bronchial mucus collection----1件: 299 💬
942Bronchitol1件: Mannitol1件: Mannitol 💬 --1件: 299 💬
943Broncho-vaxom1件: OM85---1件: 85 💬
944Bronchoalveolar lavage fluid collection----1件: 229 💬
945Bronchoalveolar samples----1件: 51 💬
946Bronchodilator response----1件: 294 💬
947Bronchoscopy with bronchoalveolar lavage----1件: 84 💬
948BRS201----2件: 94, 97 💬
949BRV 2.5 MG----1件: 309 💬
950BRV 25 MG----1件: 309 💬
951BRV 50 MG----1件: 309 💬
952BRX-345----2件: 2, 15 💬
953Bryostatin 11件: Bryostatin 1---2件: 13, 62 💬
954BS01----1件: 90 💬
955BSC----1件: 85 💬
956BSF 208075----1件: 86 💬
957BSF 208075 or LU 208075----1件: 86 💬
958BT-11----2件: 96, 97 💬
959BT-11 1000MG----2件: 96, 97 💬
960BT-11 500 MG----2件: 96, 97 💬
961BT-11 880 MG----1件: 96 💬
962BT-11 high----1件: 98 💬
963BT-11 LOW----1件: 98 💬
964BT051 200 MG----1件: 97 💬
965BT051 3200 MG----1件: 97 💬
966BT051 800 MG----1件: 97 💬
967BT061----1件: 46 💬
968BT063----1件: 49 💬
969BT090----1件: 65 💬
970BT2001件: BT200---1件: 288 💬
971BT524----1件: 65 💬
972BT595----2件: 63, 65 💬
973BT681----1件: 65 💬
974BT971----1件: 46 💬
975BTK inhibitor----3件: 46, 53, 160 💬
976BTRX-2460401件: BTRX-246040---1件: 6 💬
977BTT-1023----1件: 46 💬
978BTT1023----1件: 94 💬
979BTT1023 IV infusion 20 MG/ML, 5 ML drug product----1件: 94 💬
980BTX-A1件: Botulinum toxin type A2件: Botulinum toxin type A ,
Prabotulinumtoxin A 💬 		1件: SNAP25 💬 2件: Insulin secretion, Synaptic vesicle cycle 💬2件: 6, 149 💬
981BU zhong YI QI tang----1件: 11 💬
982Buccal (cheek) swab----2件: 89, 158 💬
983Bucelipase alfa1件: Bucelipase alfa---1件: 299 💬
984Bucillamine1件: Bucillamine1件: Bucillamine 💬 --1件: 46 💬
985Buckwheat1件: Buckwheat---1件: 226 💬
986Bucladesine1件: Bucladesine1件: Bucladesine 💬 16件: PDE1,
PDE1,
PDE1,
PDE10,
PDE11,
PDE2A,
PDE3A,
PDE3B,
PDE4,
PDE4,
PDE4,
PDE4,
PDE7,
PDE7,
PDE8,
PDE8 💬 		17件: Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Cortisol synthesis and secretion, Cushing syndrome, Glucagon signaling pathway, Insulin signaling pathway, Morphine addiction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Progesterone-mediated oocyte maturation, Purine metabolism, Regulation of lipolysis in adipocytes, Renin secretion, Taste transduction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 246 💬
987Budenofalk----1件: 96 💬
988Budenofalk 2MG rectal foam----1件: 97 💬
989Budenofalk 3MG----1件: 97 💬
990Budenofalk 3MG gastro-resistant capsules----1件: 96 💬
991Budenofalk 9MG gastro-resistant granules----1件: 96 💬
992Budenofalk rectal foam----1件: 97 💬
993Budenofalk® suppositories----1件: 97 💬
994Budesonid----1件: 95 💬
995Budesonide1件: Budesonide1件: Budesonide 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬7件: 66, 93, 94, 95, 96, 97, 98 💬
996Budesonide 0.5 MG compresse orodispersibili1件: Budesonide1件: Budesonide 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 98 💬
997Budesonide 0.5 MG orodispersible tablets1件: Budesonide1件: Budesonide 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 98 💬
998Budesonide 0.5MG orodispersible tablet twice daily1件: Budesonide1件: Budesonide 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 98 💬
999Budesonide 1 MG compresse orodispersibili1件: Budesonide1件: Budesonide 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 98 💬
1000Budesonide 1 MG orodispersible tablets1件: Budesonide1件: Budesonide 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 98 💬
1001Budesonide 1MG orodispersible tablet twice daily1件: Budesonide1件: Budesonide 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 98 💬
1002Budesonide [0.4MG/ML] viscous suspension1件: Budesonide1件: Budesonide 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 98 💬
1003Budesonide GEL1件: Budesonide1件: Budesonide 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 98 💬
1004Budesonide MMX1件: Budesonide1件: Budesonide 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 97 💬
1005Budesonide MMX 6 MG tablet1件: Budesonide1件: Budesonide 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 97 💬
1006Budesonide MMX® 6 MG1件: Budesonide1件: Budesonide 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 97 💬
1007Budesonide MMX® 9 MG1件: Budesonide1件: Budesonide 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 97 💬
1008Budesonide oral suspension1件: Budesonide1件: Budesonide 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 98 💬
1009Budesonide plus prevacid1件: Budesonide1件: Budesonide 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 98 💬
1010Budesonide-formoterol single inhaler1件: Budesonide1件: Budesonide 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 299 💬
1011Budesonide-MMX1件: Budesonide1件: Budesonide 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 97 💬
1012Budesonide-MMX® 6 MG1件: Budesonide1件: Budesonide 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 97 💬
1013Budesonide-MMX® 9 MG1件: Budesonide1件: Budesonide 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 97 💬
1014Budesonide/formoterol1件: Budesonide1件: Budesonide 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 228 💬
1015Budezonide----1件: 96 💬
1016Budoprutug1件: Budoprutug---1件: 49 💬
1017Buet 0.5 MG----1件: 98 💬
1018Buet 1 MG----1件: 98 💬
1019Buet 1MG----1件: 98 💬
1020Buet 2MG----1件: 98 💬
1021BUL 0.5 MG----1件: 98 💬
1022BUL 1 MG----1件: 98 💬
1023Buloxibutid1件: Buloxibutid2件: Buloxibutid ,
Buloxibutid sodium 💬 		2件: AGTR1,
AGTR2 💬 		17件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 85 💬
1024Bumekizumab----1件: 46 💬
1025Bumetanide1件: Bumetanide1件: Bumetanide 💬 1件: SLC12A2 💬 3件: Pancreatic secretion, Salivary secretion, Vibrio cholerae infection 💬1件: 158 💬
1026Bumetanide white, oblong, scored tablet1件: Bumetanide1件: Bumetanide 💬 1件: SLC12A2 💬 3件: Pancreatic secretion, Salivary secretion, Vibrio cholerae infection 💬1件: 6 💬
1027Buntanetap----1件: 6 💬
1028Buntanetap/posiphen----1件: 6 💬
1029BUPI5----1件: 53 💬
1030Bupivacaine1件: Bupivacaine2件: Bupivacaine hydrochloride ,
Bupivacaine 💬 		5件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬 		3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬3件: 70, 168, 226 💬
1031Bupivacaine hydrochloride1件: Bupivacaine2件: Bupivacaine hydrochloride ,
Bupivacaine 💬 		5件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬 		3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬2件: 46, 53 💬
1032Bupivacaine-epinephrine 0.25%-1:200,000 injectable solution plus clonidine1件: Bupivacaine2件: Bupivacaine hydrochloride ,
Bupivacaine 💬 		5件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬 		3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬1件: 70 💬
1033Bupivacaine/epinephrine/dexamethasone1件: Bupivacaine2件: Bupivacaine hydrochloride ,
Bupivacaine 💬 		5件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬 		3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬1件: 96 💬
1034BupivacaïNE HCL 0,125% / sufentanil 50 µG flacon à 50 ML1件: Sufentanil2件: Sufentanil citrate ,
Sufentanil 💬 		1件: OPRM1 💬 5件: Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬1件: 70 💬
1035Bupivicaine alone----1件: 298 💬
1036Bupizenge----1件: 53 💬
1037Bupleurum+ginkgo----1件: 6 💬
1038Buprenorphine1件: Buprenorphine2件: Buprenorphine hydrochloride ,
Buprenorphine 💬 		2件: OPRK1,
OPRM1 💬 		5件: Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬2件: 70, 298 💬
1039Buprenorphine transdermal patch1件: Buprenorphine2件: Buprenorphine hydrochloride ,
Buprenorphine 💬 		2件: OPRK1,
OPRM1 💬 		5件: Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬1件: 46 💬
1040Bupropion1件: Bupropion3件: Bupropion hydrochloride ,
Bupropion ,
Bupropion hydrobromide 💬 		2件: SLC6A2,
SLC6A3 💬 		8件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Neuroactive ligand signaling, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬3件: 8, 21, 96 💬
1041Bupropion & citalopram1件: Bupropion3件: Bupropion hydrochloride ,
Bupropion ,
Bupropion hydrobromide 💬 		2件: SLC6A2,
SLC6A3 💬 		8件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Neuroactive ligand signaling, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬1件: 18 💬
1042Bupropion hydrochloride1件: Bupropion3件: Bupropion hydrochloride ,
Bupropion ,
Bupropion hydrobromide 💬 		2件: SLC6A2,
SLC6A3 💬 		8件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Neuroactive ligand signaling, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬1件: 171 💬
1043Bupropion-SR1件: Bupropion3件: Bupropion hydrochloride ,
Bupropion ,
Bupropion hydrobromide 💬 		2件: SLC6A2,
SLC6A3 💬 		8件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Neuroactive ligand signaling, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬1件: 97 💬
1044Burfiralimab1件: Burfiralimab---1件: 46 💬
1045Burlulipase1件: Burlulipase---1件: 299 💬
1046Burosumab1件: Burosumab1件: Burosumab 💬 1件: FGF23 💬 11件: Breast cancer, Calcium signaling pathway, Gastric cancer, MAPK signaling pathway, Melanoma, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton 💬1件: 238 💬
1047Bushen quhan zhiwang decoction----1件: 46 💬
1048Busilvex1件: Busulfan1件: Busulfan 💬 --4件: 19, 36, 60, 65 💬
1049Busilvex - 6 MG/ML - concentrato PER soluzione PER infusione - USO endovenoso - flaconcino - 10 ML 8 flaconcini1件: Busulfan1件: Busulfan 💬 --2件: 19, 65 💬
1050Buspirone1件: Buspirone2件: Buspirone hydrochloride ,
Buspirone 💬 		2件: DRD2,
HTR1 💬 		12件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Serotonergic synapse, Taste transduction, cAMP signaling pathway 💬3件: 6, 51, 179 💬
1051Buspirone cloridrato1件: Buspirone2件: Buspirone hydrochloride ,
Buspirone 💬 		2件: DRD2,
HTR1 💬 		12件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Serotonergic synapse, Taste transduction, cAMP signaling pathway 💬1件: 6 💬
1052Buspirone hydrochloride1件: Buspirone2件: Buspirone hydrochloride ,
Buspirone 💬 		2件: DRD2,
HTR1 💬 		12件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Serotonergic synapse, Taste transduction, cAMP signaling pathway 💬1件: 6 💬
1053Busulfan1件: Busulfan1件: Busulfan 💬 --14件: 19, 20, 28, 34, 36, 49, 51, 60, 65, 164, 274, 284, 285, 326 💬
1054Busulfan test dose1件: Busulfan1件: Busulfan 💬 --1件: 65 💬
1055Busulfan, cyclophosphamide, antithymocyte globulin1件: Busulfan1件: Busulfan 💬 --2件: 19, 20 💬
1056Busulfan, cyclophosphamide, ATG1件: Busulfan1件: Busulfan 💬 --1件: 19 💬
1057Busulfan, cyclophosphamide, ATG, gcsf1件: Busulfan1件: Busulfan 💬 --2件: 65, 284 💬
1058Busulfan, fludarabine, ATG, TLI1件: Busulfan1件: Busulfan 💬 --2件: 65, 284 💬
1059Busulfan/fludarabine phosphate/tacrolimus/methotrexate/G-CSF1件: Busulfan1件: Busulfan 💬 --1件: 60 💬
1060Busulfano1件: Busulfan1件: Busulfan 💬 --1件: 19 💬
1061Butanoic acid1件: Butyric Acid1件: Sodium butyrate 💬 --1件: 97 💬
1062Butylphthalide1件: Butylphthalide---3件: 2, 6, 22 💬
1063Butyrate1件: Butyric Acid1件: Sodium butyrate 💬 --2件: 46, 97 💬
1064Butyrate enemas + routine management1件: Butyric Acid1件: Sodium butyrate 💬 --1件: 291 💬
1065Butyric acid1件: Butyric Acid1件: Sodium butyrate 💬 --1件: 222 💬
1066BUU 0.4MG/ML----1件: 98 💬
1067BV-101----1件: 8 💬
1068Bvec----1件: 36 💬
1069BVS857----1件: 1 💬
1070BW-20805----1件: 65 💬
1071BX-1----1件: 13 💬
1072BX004-A----1件: 299 💬
1073BY demand----2件: 96, 97 💬
1074Bydureon1件: Exenatide1件: Exenatide 💬 1件: GLP1R 💬 4件: Hormone signaling, Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬2件: 6, 17 💬
1075Bydureon 2 MG powder and solvent FOR prolonged-release suspension1件: Exenatide1件: Exenatide 💬 1件: GLP1R 💬 4件: Hormone signaling, Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 6 💬
1076Byetta1件: Exenatide1件: Exenatide 💬 1件: GLP1R 💬 4件: Hormone signaling, Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬2件: 78, 193 💬
1077Byetta 5 micrograms1件: Exenatide1件: Exenatide 💬 1件: GLP1R 💬 4件: Hormone signaling, Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 6 💬
1078BYM338----1件: 15 💬
1079BYM338/bimagrumab----1件: 15 💬
1080Béfizal----1件: 302 💬